Skip to main content

MARSHALL WACE, LLP

Position in TVTX — Travere Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in TVTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$75,739,488
+$70,435,184 QoQ
Shares Held
1,333,207
+646.7% QoQ
Ownership
1.41%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#24
of 317 holders
Holding Since
Jun 2020
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in TVTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. TVTX ranks #6 (2.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 TVTX
Travere Therapeutics, Inc.
This page
1,333,207 $75,739,488

All Filings in TVTX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $75,739,488 1,333,207
2026-03-31 $5,304,304 178,536
2025-12-31 $8,298,103 217,171
2025-09-30 $14,102,218 590,051
2025-06-30 $10,992,330 742,725
2024-09-30 $1,557,660 111,341
2023-09-30 $655,588 73,332
2023-03-31 $4,824,060 214,498
2021-12-31 $213,120 6,866
2021-09-30 $1,268,444 52,307
2021-03-31 $4,349,599 174,193
2020-06-30 RTRX 98,976